Serial Number
97925396
Owner
Sarepta Therapeutics, Inc.Attorney
Maury M. Tepper, IIIFirst Use Date
Nov 14, 2025
Filing Date
May 8, 2023
ELEVIDYS Trademark
Serial Number: 97925396 • Registration: 8285581
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Maury M. Tepper, III TEPPER & EYSTER, PLLC
3724 BENSON DRIVE
RALEIGH, NC 27609
United States
Trademark Details
Filing Date
May 8, 2023
Registration Date
June 2, 2026
First Use Anywhere
November 14, 2025
First Use in Commerce
November 14, 2025
Published for Opposition
November 19, 2024
Goods & Services
Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Gene therapy products, namely, gene delivery pharmaceuticals; Pharmaceutical preparations for gene therapy, gene editing, and genome editing; Gene therapy products in the nature of pharmaceuticals for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Viruses, viral vectors and viral constructs being pharmaceuticals for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases
